- Home
- HPP vs PACB Comparison
HPP vs PACB Comparison
Compare HPP & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPP
- PACB
- Stock Information
- Founded
- HPP 1997
- PACB 2000
- Country
- HPP United States
- PACB United States
- Employees
- HPP N/A
- PACB N/A
- Industry
- HPP Real Estate
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- HPP Finance
- PACB Industrials
- Exchange
- HPP Nasdaq
- PACB Nasdaq
- Market Cap
- HPP 319.5M
- PACB 364.2M
- IPO Year
- HPP 2010
- PACB 2010
- Fundamental
- Price
- HPP $2.27
- PACB $1.12
- Analyst Decision
- HPP Hold
- PACB Buy
- Analyst Count
- HPP 10
- PACB 10
- Target Price
- HPP $3.19
- PACB $2.45
- AVG Volume (30 Days)
- HPP 2.4M
- PACB 6.4M
- Earning Date
- HPP 05-07-2025
- PACB 05-08-2025
- Dividend Yield
- HPP 2.18%
- PACB N/A
- EPS Growth
- HPP N/A
- PACB N/A
- EPS
- HPP N/A
- PACB N/A
- Revenue
- HPP $818,699,000.00
- PACB $152,357,000.00
- Revenue This Year
- HPP $0.13
- PACB $6.13
- Revenue Next Year
- HPP $5.00
- PACB $21.55
- P/E Ratio
- HPP N/A
- PACB N/A
- Revenue Growth
- HPP N/A
- PACB N/A
- 52 Week Low
- HPP $2.00
- PACB $1.06
- 52 Week High
- HPP $6.29
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- HPP 45.45
- PACB 44.27
- Support Level
- HPP $2.09
- PACB $1.06
- Resistance Level
- HPP $2.38
- PACB $1.23
- Average True Range (ATR)
- HPP 0.15
- PACB 0.07
- MACD
- HPP 0.04
- PACB 0.01
- Stochastic Oscillator
- HPP 68.42
- PACB 31.58
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.